Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.


DocPlanner.com, an online booking platform for healthcare appointments, has raised $20 million in Series C financing led by Target Global. Also contributing to the round were ENERN Investments and EBRD. Additionally, the company will create the biggest online healthcare booking platform in the world by merging with Doctoralia.com, a Spain-based competitor. The funds will also finance expansion into other foreign markets and further the development of the company’s online practice management software solution.

 DocPlanner is a marketplace and cloud software for private healthcare providers – including individual doctors, dentists and other healthcare professionals such as dietitians and psychologists, as well as small and large clinics. Doctors can use its services to manage their professional profile; follow and respond to opinions received from patients; offer an online calendar to their existing and new patients; and improve their office administration (via personal tele-assistant, automatic appointment reminders, etc.). The company currently operates websites in 25 countries and processes 200,000 bookings per month.

DocPlanner grabs $20 million for expansion

 Fast growth, a strengthening leadership position in Europe and plans to expand into new geographies have convinced new investors to fund DocPlanner further. In the recent Series C financing the company raised $20 million led by Target Global with participation by ENERN Investments and EBRD (via its Venture Capital Investment Programme).

 DocPlanner’s total funding to date stands at $34 million. Previous investors include EBRD, Point Nine Capital, Piton Capital, RTAventures, Lukasz Gadowski (Delivery Hero) and Fabrice Grinda (Airbnb, Uber).

 “We have the ambition to become the clear #1 global online platform for healthcare. The focus now is on building a stronger global presence – bolstering positions in key markets (Poland, Turkey and Italy) and adding 4-5 high growth markets, either through greenfield or acquisition. The presence and usefulness of healthcare platforms is slowly getting recognized by doctors and patients in a growing number of countries,” says Mariusz Gralewski, founder and CEO of DocPlanner. “In our key markets we are actively growing the supply of doctor calendars available to patients online and are focusing on delivering a top quality experience for both sets of users.”

 “We are proud to become an investor in DocPlanner. Our team was blown away by the market response to their unique product suite which provides better patient management, more sophisticated marketing and lead generation tools to doctors and clinics. We believe that DocPlanner’s ability to expand internationally by integrating local service providers will lead them to a position of market dominance,” commented Yaron Valler, General Partner at Target Global.

DocPlanner merges with Doctoralia

 Over the past few years both companies have established strong presences in their core markets. DocPlanner now attracts 8 million unique users monthly, with 90% coming from Europe. Doctoralia, with over 9 million unique users monthly, holds leading positions in Spain and Latin America, including Brazil and Mexico. The combined company will have 17 million unique users, paying clients in 20 markets and host the biggest database of doctors worldwide – 5 million healthcare professionals – and serve 3 million registered patient users.

 “The companies have complementary geographies and great teams. By joining forces we can leverage best practices and provide an even better software and product offering for both doctors and patients on a truly global scale,” commented Mariusz Gralewski, founder and CEO of DocPlanner.

 While the combined company will be majority-owned by former DocPlanner shareholders, the existing Doctoralia founders will become significant shareholders and will join the senior management team. The Barcelona-based team will continue to strengthen the merged company’s presence in Spain and Latin America.

 “We are thrilled to build a global healthcare leader with DocPlanner, especially that the teams share similar attitudes and there is so much we can learn from each other; we could not have asked for a better partner,” says Albert Armengol, founder and CEO of Doctoralia.